Sabra Health Care REIT (SBRA) Cash & Equivalents (2010 - 2026)

Sabra Health Care REIT's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $6.9 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 10.84% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (up 10.84% YoY), while the FY2025 annual figure was $71.5 million, up 18.31% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $6.9 million, down from $71.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $200.6 million in Q3 2025, with the low at $5.4 million in Q4 2023.
• The 5-year median for Cash & Equivalents is $33.3 million (2023), against an average of $44.5 million.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents slumped 89.05% in 2023, then surged 3259.04% in 2025.
• Sabra Health Care REIT's Cash & Equivalents stood at $49.3 million in 2022, then plunged by 89.05% to $5.4 million in 2023, then jumped by 1019.78% to $60.5 million in 2024, then grew by 18.31% to $71.5 million in 2025, then tumbled by 90.33% to $6.9 million in 2026.
• Business Quant data shows SBRA's Cash & Equivalents at $6.9 million in Q1 2026, $71.5 million in Q4 2025, and $200.6 million in Q3 2025.